Evidence map›Paper›PMID 40382341›Full record

ArticleNature communications2025

Carbon fibre production using an ecofriendly water-soluble precursor.

Takuya Morishita, Mamiko Narita, Mitsumasa Matsushita, Kenichi Hayashida, Kazuhiro Nomura, Shota Taniguchi, Yoshihiro Kikuzawa, Natsu Sakakura, Hiromitsu Tanaka, Yoshihide Katagiri and 6 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Takuya MorishitaToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan. morishita-t@mosk.tytlabs.co.jp.ORCID http://orcid.org/0000-0002-0174-1535
Mamiko NaritaToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.ORCID http://orcid.org/0009-0003-2276-225X
Mitsumasa MatsushitaToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Kenichi HayashidaToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Kazuhiro NomuraToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Shota TaniguchiToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.ORCID http://orcid.org/0009-0002-7456-1479
Yoshihiro KikuzawaToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Natsu SakakuraToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Hiromitsu TanakaToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Yoshihide KatagiriToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Atsuto OkamotoToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Makoto MouriToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Hiroyuki MoriToyota Central R&D Labs., Inc., 41-1, Yokomichi, Nagakute, Aichi, 480-1192, Japan.
Akira KunitomoToyota Motor Corporation, 1, Toyota-Cho, Toyota, Aichi, 471-8571, Japan.
Hideyasu KawaiToyota Motor Corporation, 1, Toyota-Cho, Toyota, Aichi, 471-8571, Japan.
Nozomu ShigemitsuToyota Motor Corporation, 1, Toyota-Cho, Toyota, Aichi, 471-8571, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbon fibre (CF) is a lightweight next-generation material with numerous applications. CF production is predominantly based on the polyacrylonitrile (PAN) precursor because of the high tensile strength of PAN-based CFs (PAN-CFs). However, expensive and toxic organic solvents are required for PAN-CF production. Moreover, the corresponding thermal stabilisation process is highly energy-intensive, leading to high CO

Identifiers

PMID40382341
PMCPMC12085577

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.